Seattle scientists launch $95 million AI biology effort
4 September 2026 · filed under 06f38ce16213
Seattle-based scientists have launched a new research effort backed by $95 million to apply artificial intelligence methods to biological problems, STAT News reported September 3. The outlet’s account arrived alongside other items in its regular biotechnology roundup, including news that a pivotal Phase 3 trial of an Ultragenyx drug had failed to meet its goals, and a separate report on the Food and Drug Administration’s record in regulating unproven stem cell treatments.
Details of the AI biology initiative, including the specific institutions and researchers involved, the scientific questions it intends to pursue, and the funding sources behind the $95 million figure, were not included in the available summary. STAT News published the item under its STAT+ subscription tier, titled “Biotech news: Seattle scientists launch $95 million AI biology effort.”
The report situates the Seattle project within a broader wave of investment activity in computational approaches to biological research, though the source material provided does not specify a timeline, expected deliverables, or named collaborators for the effort. No direct quotations from project participants were included in the summary provided to this desk.
Further particulars, including the scope of the AI methods to be applied and the biological systems under study, await fuller reporting. This bulletin reflects only what the cited summary makes available at time of writing.